European Journal of Nuclear Medicine and Molecular Imaging最新文献

筛选
英文 中文
Internal auditory canal tumor presented on [18F]AlF-FAPI-74 and [18F]AlF-PSMA-BCH PET/CT in a prostate cancer patient. 一名前列腺癌患者的内耳道肿瘤出现在 [18F]AlF-FAPI-74 和 [18F]AlF-PSMA-BCH PET/CT 上。
IF 8.6 1区 医学
European Journal of Nuclear Medicine and Molecular Imaging Pub Date : 2024-08-05 DOI: 10.1007/s00259-024-06859-8
Xin Cheng, Guozhu Hou, Rong Zheng, Xuejuan Wang
{"title":"Internal auditory canal tumor presented on [<sup>18</sup>F]AlF-FAPI-74 and [<sup>18</sup>F]AlF-PSMA-BCH PET/CT in a prostate cancer patient.","authors":"Xin Cheng, Guozhu Hou, Rong Zheng, Xuejuan Wang","doi":"10.1007/s00259-024-06859-8","DOIUrl":"https://doi.org/10.1007/s00259-024-06859-8","url":null,"abstract":"","PeriodicalId":11909,"journal":{"name":"European Journal of Nuclear Medicine and Molecular Imaging","volume":null,"pages":null},"PeriodicalIF":8.6,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141888841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fetal dose minimization: ultra-low dose long axial field of view (LAFOV) PET/CT imaging of a pregnant patient. 胎儿剂量最小化:妊娠患者的超低剂量长轴视野 PET/CT 成像。
IF 8.6 1区 医学
European Journal of Nuclear Medicine and Molecular Imaging Pub Date : 2024-08-03 DOI: 10.1007/s00259-024-06861-0
J H van Snick, K P Koopmans, A W J M Glaudemans, G N Stormezand, O V Ivashchenko
{"title":"Fetal dose minimization: ultra-low dose long axial field of view (LAFOV) PET/CT imaging of a pregnant patient.","authors":"J H van Snick, K P Koopmans, A W J M Glaudemans, G N Stormezand, O V Ivashchenko","doi":"10.1007/s00259-024-06861-0","DOIUrl":"https://doi.org/10.1007/s00259-024-06861-0","url":null,"abstract":"","PeriodicalId":11909,"journal":{"name":"European Journal of Nuclear Medicine and Molecular Imaging","volume":null,"pages":null},"PeriodicalIF":8.6,"publicationDate":"2024-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141888840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PSMA radioligand therapy rechallenging: expanding the therapeutic possibilities in metastatic castration resistant prostate cancer. PSMA 放射性配体疗法再挑战:拓展转移性阉割耐药前列腺癌的治疗可能性。
IF 8.6 1区 医学
European Journal of Nuclear Medicine and Molecular Imaging Pub Date : 2024-08-03 DOI: 10.1007/s00259-024-06870-z
Fabio Volpe, Leandra Piscopo, Michele Klain
{"title":"PSMA radioligand therapy rechallenging: expanding the therapeutic possibilities in metastatic castration resistant prostate cancer.","authors":"Fabio Volpe, Leandra Piscopo, Michele Klain","doi":"10.1007/s00259-024-06870-z","DOIUrl":"https://doi.org/10.1007/s00259-024-06870-z","url":null,"abstract":"","PeriodicalId":11909,"journal":{"name":"European Journal of Nuclear Medicine and Molecular Imaging","volume":null,"pages":null},"PeriodicalIF":8.6,"publicationDate":"2024-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141888842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Powering the engine of nuclear medicine: insights from the next generation congress (Milan, 2024). 为核医学提供动力:下一代大会(米兰,2024 年)的见解。
IF 8.6 1区 医学
European Journal of Nuclear Medicine and Molecular Imaging Pub Date : 2024-08-02 DOI: 10.1007/s00259-024-06867-8
Giulia Santo, Alberto Miceli
{"title":"Powering the engine of nuclear medicine: insights from the next generation congress (Milan, 2024).","authors":"Giulia Santo, Alberto Miceli","doi":"10.1007/s00259-024-06867-8","DOIUrl":"https://doi.org/10.1007/s00259-024-06867-8","url":null,"abstract":"","PeriodicalId":11909,"journal":{"name":"European Journal of Nuclear Medicine and Molecular Imaging","volume":null,"pages":null},"PeriodicalIF":8.6,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141874512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the efficacy of [177Lu]Lu-FAP-2286 in combination therapy for metastatic breast cancer. 评估[177Lu]Lu-FAP-2286联合治疗转移性乳腺癌的疗效。
IF 8.6 1区 医学
European Journal of Nuclear Medicine and Molecular Imaging Pub Date : 2024-08-02 DOI: 10.1007/s00259-024-06864-x
Serkan Kuyumcu, Duygu Has-Şimşek
{"title":"Evaluating the efficacy of [<sup>177</sup>Lu]Lu-FAP-2286 in combination therapy for metastatic breast cancer.","authors":"Serkan Kuyumcu, Duygu Has-Şimşek","doi":"10.1007/s00259-024-06864-x","DOIUrl":"https://doi.org/10.1007/s00259-024-06864-x","url":null,"abstract":"","PeriodicalId":11909,"journal":{"name":"European Journal of Nuclear Medicine and Molecular Imaging","volume":null,"pages":null},"PeriodicalIF":8.6,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141874511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to objectively evaluate the impact of image-guided surgery technologies. 如何客观评价影像引导手术技术的影响。
IF 8.6 1区 医学
European Journal of Nuclear Medicine and Molecular Imaging Pub Date : 2024-08-01 Epub Date: 2023-11-16 DOI: 10.1007/s00259-023-06504-w
Jonathan M Sorger
{"title":"How to objectively evaluate the impact of image-guided surgery technologies.","authors":"Jonathan M Sorger","doi":"10.1007/s00259-023-06504-w","DOIUrl":"10.1007/s00259-023-06504-w","url":null,"abstract":"<p><strong>Purpose: </strong>This manuscript aims to provide a better understanding of methods and techniques with which one can better quantify the impact of image-guided surgical technologies.</p><p><strong>Methods: </strong>A literature review was conducted with regard to economic and technical methods of medical device evaluation in various countries. Attention was focused on applications related to image-guided interventions that have enabled procedures to be performed in a minimally invasive manner, produced superior clinical outcomes, or have become standard of care.</p><p><strong>Results: </strong>The review provides examples of successful implementations and adoption of image-guided surgical techniques, mostly in the field of neurosurgery. Failures as well as newly developed technologies still undergoing cost-efficacy analysis are discussed.</p><p><strong>Conclusion: </strong>The field of image-guided surgery has evolved from solely using preoperative images to utilizing highly specific tools and software to provide more information to the interventionalist in real time. While deformations in soft tissue often preclude the use of such instruments outside of neurosurgery, recent developments in optical and radioactive guidance have enabled surgeons to better account for organ motion and provide feedback to the surgeon as tissue is cut. These technologies are currently undergoing value assessments in many countries and hold promise to improve outcomes for patients, surgeons, care teams, payors, and society in general.</p>","PeriodicalId":11909,"journal":{"name":"European Journal of Nuclear Medicine and Molecular Imaging","volume":null,"pages":null},"PeriodicalIF":8.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136396866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Towards molecular imaging-guided intervention theatres in oncology. 肿瘤分子成像引导介入手术室的发展。
IF 8.6 1区 医学
European Journal of Nuclear Medicine and Molecular Imaging Pub Date : 2024-08-01 DOI: 10.1007/s00259-023-06545-1
J Vonk, S Kruijff, R H J A Slart, W Szymanski, M J H Witjes, A W J M Glaudemans
{"title":"Towards molecular imaging-guided intervention theatres in oncology.","authors":"J Vonk, S Kruijff, R H J A Slart, W Szymanski, M J H Witjes, A W J M Glaudemans","doi":"10.1007/s00259-023-06545-1","DOIUrl":"10.1007/s00259-023-06545-1","url":null,"abstract":"","PeriodicalId":11909,"journal":{"name":"European Journal of Nuclear Medicine and Molecular Imaging","volume":null,"pages":null},"PeriodicalIF":8.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138444369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current clinical applications of Cerenkov luminescence for intraoperative molecular imaging. 用于术中分子成像的 Cerenkov 发光技术的临床应用现状。
IF 8.6 1区 医学
European Journal of Nuclear Medicine and Molecular Imaging Pub Date : 2024-08-01 Epub Date: 2024-01-20 DOI: 10.1007/s00259-024-06602-3
Natalie Boykoff, Jan Grimm
{"title":"Current clinical applications of Cerenkov luminescence for intraoperative molecular imaging.","authors":"Natalie Boykoff, Jan Grimm","doi":"10.1007/s00259-024-06602-3","DOIUrl":"10.1007/s00259-024-06602-3","url":null,"abstract":"<p><strong>Background: </strong>Cerenkov luminescence imaging (CLI) is a new emerging technology that can be used for optical imaging of approved radiotracers, both in a preclinical, and even more recently, in a clinical context with rapid imaging times, low costs, and detection in real-time (Grootendorst et al. Clin Transl Imaging 4(5):353-66, 2016); Wang et al. Photonics 9(6):390, 2022). This brief review provides an overview of clinical applications of CLI with a focus on intraoperative margin assessment (IMA) to address shortcomings and provide insight for future work in this application.</p><p><strong>Methods: </strong>A literature review was performed using PubMed using the search words Cerenkov luminescence imaging (CLI), intraoperative margin assessment (IMA), and image-guided surgery. Articles were selected based on title, abstract, content, and application.</p><p><strong>Results: </strong>Original research was summarized to examine advantages and limitations of CLI compared to other modalities for IMA. The characteristics of Cerenkov luminescence (CL) are defined, and results from relevant clinical trials are discussed. Prospects of ongoing clinical trials are reviewed, along with technological advancements related to CLI.</p><p><strong>Conclusion: </strong>CLI is a proven method for molecular imaging and shows feasibility for determining intraoperative margins if future work involves establishing quantitative approaches for attenuation and scattering, depth analysis, and radiation safety for CLI at a larger scale.</p>","PeriodicalId":11909,"journal":{"name":"European Journal of Nuclear Medicine and Molecular Imaging","volume":null,"pages":null},"PeriodicalIF":8.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139501913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CT-guided percutaneous marking of small pulmonary nodules with [99mTc]Tc-Macrosalb is very accurate and allows minimally invasive lung-sparing resection: a single-centre quality control. 用[99m锝]锝-Macrosalb在CT引导下经皮标记肺小结节非常准确,可进行微创保肺切除术:单中心质量控制。
IF 8.6 1区 医学
European Journal of Nuclear Medicine and Molecular Imaging Pub Date : 2024-08-01 Epub Date: 2023-08-31 DOI: 10.1007/s00259-023-06410-1
Nikola Doncic, Christoph J Zech, Damian Wild, Helga Bachmann, Makhmudbek Mallaev, Nikolay Tsvetkov, Aljaz Hojski, Martin T L Takes, Didier Lardinois
{"title":"CT-guided percutaneous marking of small pulmonary nodules with [<sup>99m</sup>Tc]Tc-Macrosalb is very accurate and allows minimally invasive lung-sparing resection: a single-centre quality control.","authors":"Nikola Doncic, Christoph J Zech, Damian Wild, Helga Bachmann, Makhmudbek Mallaev, Nikolay Tsvetkov, Aljaz Hojski, Martin T L Takes, Didier Lardinois","doi":"10.1007/s00259-023-06410-1","DOIUrl":"10.1007/s00259-023-06410-1","url":null,"abstract":"<p><strong>Purpose: </strong>The detection of small lung nodules in thoracoscopic procedure is difficult when the lesions are not located within the outer border of the lung. In the case of ground-glass opacities, it is often impossible to palpate the lesion. Marking lung nodules using a radiotracer is a known technique. We analysed the accuracy and safety of the technique and the potential benefits of operating in a hybrid operating room.</p><p><strong>Methods: </strong>57 patients, including 33 (58%) females with a median age of 67 years (range 21-82) were included. In 27 patients, we marked and resected the lesion in a hybrid room. In 30 patients, the lesion was marked at the department of radiology the day before resection. [<sup>99m</sup>Tc]Tc-Macrosalb (Pulmocis<sup>®</sup>) was used at an activity of 1 MBq in the hybrid room and at an activity of 3 MBq the day before to get technical feasible results. Radioactivity was detected using the Neoprobe<sup>®</sup> detection system.</p><p><strong>Results: </strong>Precise detection and resection of the nodules was possible in 95% of the lesions and in 93% of the patients. Complete thoracoscopic resection was possible in 90% of the patients. Total conversion rate was 10%, but conversion due to failure of the marking of the nodule was observed in only 5% of the patients. Histology revealed 28 (37%) primary lung cancers, 24 (32%) metastases and 21 (28%) benign lesions. In 13 (23%) patients, minor complications were observed. None of them required additional interventions.</p><p><strong>Conclusion: </strong>The radio-guided detection of small pulmonary nodules is very accurate and safe after CT-guided injection of [<sup>99m</sup>Tc]Tc-Macrosalb. Performing the operation in a hybrid room has several logistic advantages and allows using lower technetium-99m activities. The technique allows minimally invasive lung sparing resection and prevents overtreatment of benign and metastatic lesions.</p>","PeriodicalId":11909,"journal":{"name":"European Journal of Nuclear Medicine and Molecular Imaging","volume":null,"pages":null},"PeriodicalIF":8.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11300552/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10122672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intraoperative molecular imaging of colorectal lung metastases with SGM-101: a feasibility study. 使用 SGM-101 对结直肠肺转移灶进行术中分子成像:一项可行性研究。
IF 8.6 1区 医学
European Journal of Nuclear Medicine and Molecular Imaging Pub Date : 2024-08-01 Epub Date: 2023-08-08 DOI: 10.1007/s00259-023-06365-3
Ruben P J Meijer, Hidde A Galema, Robin A Faber, Okker D Bijlstra, Alexander P W M Maat, Françoise Cailler, Jerry Braun, Stijn Keereweer, Denise E Hilling, Jacobus Burggraaf, Alexander L Vahrmeijer, Merlijn Hutteman
{"title":"Intraoperative molecular imaging of colorectal lung metastases with SGM-101: a feasibility study.","authors":"Ruben P J Meijer, Hidde A Galema, Robin A Faber, Okker D Bijlstra, Alexander P W M Maat, Françoise Cailler, Jerry Braun, Stijn Keereweer, Denise E Hilling, Jacobus Burggraaf, Alexander L Vahrmeijer, Merlijn Hutteman","doi":"10.1007/s00259-023-06365-3","DOIUrl":"10.1007/s00259-023-06365-3","url":null,"abstract":"<p><strong>Purpose: </strong>Metastasectomy is a common treatment option for patients with colorectal lung metastases (CLM). Challenges exist with margin assessment and identification of small nodules, especially during minimally invasive surgery. Intraoperative fluorescence imaging has the potential to overcome these challenges. The aim of this study was to assess feasibility of targeting CLM with the carcinoembryonic antigen (CEA) specific fluorescent tracer SGM-101.</p><p><strong>Methods: </strong>This was a prospective, open-label feasibility study. The primary outcome was the number of CLM that showed a true positive fluorescence signal with SGM-101. Fluorescence positive signal was defined as a signal-to-background ratio (SBR) ≥ 1.5. A secondary endpoint was the CEA expression in the colorectal lung metastases, assessed with the immunohistochemistry, and scored by the total immunostaining score.</p><p><strong>Results: </strong>Thirteen patients were included in this study. Positive fluorescence signal with in vivo, back table, and closed-field bread loaf imaging was observed in 31%, 45%, and 94% of the tumors respectively. Median SBRs for the three imaging modalities were 1.00 (IQR: 1.00-1.53), 1.45 (IQR: 1.00-1.89), and 4.81 (IQR: 2.70-7.41). All tumor lesions had a maximum total immunostaining score for CEA expression of 12/12.</p><p><strong>Conclusion: </strong>This study demonstrated the potential of fluorescence imaging of CLM with SGM-101. CEA expression was observed in all tumors, and closed-field imaging showed excellent CEA specific targeting of the tracer to the tumor nodules. The full potential of SGM-101 for in vivo detection of the tracer can be achieved with improved minimal invasive imaging systems and optimal patient selection.</p><p><strong>Trial registration: </strong>The study was registered in ClinicalTrial.gov under identifier NCT04737213 at February 2021.</p>","PeriodicalId":11909,"journal":{"name":"European Journal of Nuclear Medicine and Molecular Imaging","volume":null,"pages":null},"PeriodicalIF":8.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11300526/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9954680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信